National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Bilastine (Drynol®) for the Symptomatic treatment of allergic rhino-conjunctivitis (seasonal and perennial) and urticaria.

Rapid Review

Commenced Completed Outcome
10/03/2011 23/03/2011 Full Pharmacoeconomic Evaluation not Recommended.